Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
Clinical trial NCT00570765 · COMPLETED
Trial details
- NCT number
- NCT00570765
- Sponsor
- Intercept Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-17
- Primary completion
- 2010-09-21
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.